Volume 13, Number 1—January 2007
Research
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Rebecca H. Sunenshine*, Marc-Oliver Wright†, Lisa L. Maragakis‡, Anthony D. Harris†, Xiaoyan Song‡, Joan Hebden†, Sara E. Cosgrove‡, Ashley Anderson*, Jennifer Carnell*, Daniel B. Jernigan*, David G. Kleinbaum*, Trish M. Perl‡, Harold C. Standiford†, and Arjun Srinivasan*
Table 1
Comparison of baseline characteristics of patients with multidrug-resistant (MDR) Acinetobacter infection with those with susceptible Acinetobacter infection and those without Acinetobacter infection, Baltimore hospitals, 2003– 2004*
| Characteristic | MDR Acinetobacter, n = 96 | Susceptible Acinetobacter, n = 91 | p values for MDR Acinetobacter vs. susceptible, n = 187 | Uninfected, n = 89 | p values for MDR Acinetobacter vs. uninfected, n = 185 |
|---|---|---|---|---|---|
| Median age, y | 54 | 52 | 0.61 | 52 | 0.97 |
| Age range, y | 14–83 | 12–85 | 17–90 | ||
| Sex, % male | 67 | 57 | 0.78 | 65 | 0.96 |
| Mean modified APACHE III score (median) | 41 (42) | 36 (33) | 0.02 | 32 (28) | <0.001 |
| Mean Charlson index (median) | 3.9 (3.0) | 2.8 (2.0) | 0.01 | 2.5 (2.0) | <0.01 |
*APACHE III, Acute Physiology and Chronic Health Evaluation III.
Page created: June 28, 2010
Page updated: June 28, 2010
Page reviewed: June 28, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.